Related Experiment Videos
Multiple use of dialysers: an Australian view
Nephron
|January 1, 1981
Summary
Dialyzer reuse in Australian hospitals significantly saves costs and shows comparable patient survival rates to single-use policies. However, a low but increasing frequency of anti-N-like antibodies is being detected.
Area of Science:
- Nephrology
- Medical Technology
- Public Health
Background:
- Dialyzer reuse is a practice explored to reduce healthcare costs in hemodialysis.
- Previous studies have assessed the economic and clinical impact of dialyzer reuse within single institutions.
- A comprehensive understanding of its widespread adoption and outcomes across Australia was needed.
Purpose of the Study:
- To evaluate the economic benefits of dialyzer reuse in a hospital setting.
- To assess the safety and efficacy of dialyzer reuse by surveying Australian dialysis units.
- To investigate patient survival rates and potential immunologic effects associated with dialyzer reuse.
Main Methods:
- A cost-saving analysis was conducted in a 46-patient hospital unit.
- A survey was distributed to all Australian dialysis units to gather data on reuse practices.
- Patient survival data and antibody frequencies were collected and analyzed.
Main Results:
- An annual saving of $84,000 was achieved in the studied hospital unit.
- No significant increases in patient morbidity or mortality were observed.
- In Australia, 43% of hemodialysis patients are on a multiple-use regime.
- One-year patient cumulative survival was 92.8% for reuse units versus 87.1% for single-use units.
- Low but increasing frequencies of anti-N-like antibodies were detected.
Conclusions:
- Dialyzer reuse offers substantial cost savings without compromising patient safety or survival.
- The practice is widely adopted in Australia, with positive survival outcomes.
- Ongoing monitoring for anti-N-like antibodies is recommended as reuse programs continue.